Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Luteinizing hormone-releasing hormone (LHRH) receptor agonists vs antagonists: a matter of the receptors?

Tolkach Y, Joniau S, Van Poppel H.

BJU Int. 2013 Jun;111(7):1021-30. doi: 10.1111/j.1464-410X.2013.11796.x. Epub 2013 Feb 18. Review.

PMID:
23418666
[PubMed - indexed for MEDLINE]
2.

Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.

Msaouel P, Diamanti E, Tzanela M, Koutsilieris M.

Expert Opin Emerg Drugs. 2007 May;12(2):285-99. Review.

PMID:
17604502
[PubMed - indexed for MEDLINE]
3.

Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.

Hall MC, Fritzsch RJ, Sagalowsky AI, Ahrens A, Petty B, Roehrborn CG.

Urology. 1999 May;53(5):898-902; discussion 902-3.

PMID:
10223480
[PubMed - indexed for MEDLINE]
4.
5.

New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.

Garnick MB, Mottet N.

BJU Int. 2012 Aug;110(4):499-504. doi: 10.1111/j.1464-410X.2011.10708.x. Epub 2011 Nov 16.

PMID:
22093775
[PubMed - indexed for MEDLINE]
6.

The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.

Kluth LA, Shariat SF, Kratzik C, Tagawa S, Sonpavde G, Rieken M, Scherr DS, Pummer K.

World J Urol. 2014 Jun;32(3):669-76. doi: 10.1007/s00345-013-1157-5. Epub 2013 Sep 3.

PMID:
23999854
[PubMed - in process]
7.

Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats.

Kovacs M, Seprodi J, Koppan M, Horvath JE, Vincze B, Teplan I, Flerko B.

J Neuroendocrinol. 2002 Aug;14(8):647-55.

PMID:
12153467
[PubMed - indexed for MEDLINE]
8.

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

Engel JB, Schally AV.

Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):157-67. Review.

PMID:
17237842
[PubMed - indexed for MEDLINE]
9.

The role of LHRH antagonists in the treatment of prostate cancer.

Crawford ED, Hou AH.

Oncology (Williston Park). 2009 Jun;23(7):626-30. Review.

PMID:
19626830
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Comparisons of the potential utility of LHRH agonists and antagonists for fertility control.

Vickery BH.

J Steroid Biochem. 1985 Nov;23(5B):779-91. Review.

PMID:
3001420
[PubMed - indexed for MEDLINE]
12.

The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.

Tomera K, Gleason D, Gittelman M, Moseley W, Zinner N, Murdoch M, Menon M, Campion M, Garnick MB.

J Urol. 2001 May;165(5):1585-9.

PMID:
11342922
[PubMed - indexed for MEDLINE]
13.

Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.

Horvath JE, Toller GL, Schally AV, Bajo AM, Groot K.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4996-5001. Epub 2004 Mar 24.

PMID:
15044692
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?

Pickles T, Hamm J, Morris WJ, Schreiber WE, Tyldesley S.

BJU Int. 2012 Dec;110(11 Pt B):E500-7. doi: 10.1111/j.1464-410X.2012.11190.x. Epub 2012 May 7.

PMID:
22564197
[PubMed - indexed for MEDLINE]
15.

Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.

Labrie F, Bélanger A, Kelly PA, Séguin C, Cusan L, Lefebvre FA, Reeves JJ, Lemay A, Faure N, Gourdeau Y, Raynaud JP.

Prog Clin Biol Res. 1981;74:273-91. Review.

PMID:
6275404
[PubMed - indexed for MEDLINE]
16.

Luteinizing hormone-releasing hormone antagonists in prostate cancer.

Stricker HJ.

Urology. 2001 Aug;58(2 Suppl 1):24-7.

PMID:
11502441
[PubMed - indexed for MEDLINE]
17.

Degarelix: a new approach for the treatment of prostate cancer.

Persson BE, Kold Olesen T, Jensen JK.

Neuroendocrinology. 2009;90(3):235-44. doi: 10.1159/000228832. Epub 2009 Jul 14.

PMID:
19602868
[PubMed - indexed for MEDLINE]
18.

Regulation of testicular steroidogenesis by gonadotropin-releasing hormone agonists and antagonists.

Huhtaniemi I, Nikula H, Rannikko S, Clayton R.

J Steroid Biochem. 1986 Jan;24(1):169-76.

PMID:
3009972
[PubMed - indexed for MEDLINE]
19.
20.

Elevation of serum testosterone during chronic LHRH agonist treatment in the bull.

Melson BE, Brown JL, Schoenemann HM, Tarnavsky GK, Reeves JJ.

J Anim Sci. 1986 Jan;62(1):199-207.

PMID:
3007418
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk